Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Trial of an Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Sarcomas
NCT04199026Recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2025
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoints: Safety and technical feasibility of microdevice insertion/removal up to 1 year and Efficacy across all individual agents or drug combinations tested up to 1 year. Started Feb 2025; status: recruiting.
Beyond the preview
Go deeper on NCT04199026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04199026.